ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
3.730
-0.190 (-4.85%)
At close: Oct 27, 2026, 4:00 PM EDT
3.725
-0.005 (-0.13%)
Pre-market: Oct 28, 2026, 5:24 AM EDT
ARS Pharmaceuticals Market Cap
ARS Pharmaceuticals has a market cap or net worth of $370.94 million as of October 27, 2026. It is the 16,608th most valuable company in the world and the 2,970th biggest in the United States. Its market cap has decreased by 58.80% in one year.
Market Cap
370.94M
Enterprise Value
398.70M
1-Year Change
-58.80%
Global Rank
Country Rank
#2,970 United States
Category
ChartMarket Cap Chart
Since November 9, 2022, ARS Pharmaceuticals's market cap has decreased from $568.25M to $370.94M, a decrease of -34.72%. That is a compound annual growth rate of -10.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 370.94M | -67.79% |
| Dec 31, 2025 | 1.15B | 12.32% |
| Dec 31, 2024 | 1.03B | 94.90% |
| Dec 29, 2023 | 526.06M | -34.23% |
| Dec 30, 2022 | 799.86M | 40.76% |
| Nov 9, 2022 | 568.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ProKidney | 426.27M |
| Ovid Therapeutics | 421.84M |
| Prothena Corporation | 420.96M |
| Altimmune | 412.38M |
| Nautilus Biotechnology | 412.31M |
| Autolus Therapeutics | 409.89M |
| Rezolute | 404.38M |
| Assembly Biosciences | 403.95M |